Model-based population pharmacokinetic analysis of tislelizumab in patients with advanced tumors

Budha, N; Wu, CY; Tang, ZY; Yu, T; Liu, LCY; Xu, FY; Gao, YY; Li, RY; Zhang, QY; Wan, Y; Sahasranaman, S

Sahasranaman, S (通讯作者)，BeiGene USA Inc, Clin Pharmacol, 1840 Gateway Dr, San Mateo, CA 94404 USA.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023; 12 (1): 95

Abstract

Tislelizumab, a humanized immunoglobulin G4 monoclonal antibody, is a programmed cell death protein 1 (PD-1) inhibitor designed to minimize Fc gamma r......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索